Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

GM-CSF in the lung protects against lethal influenza infection.

Huang FF, Barnes PF, Feng Y, Donis R, Chroneos ZC, Idell S, Allen T, Perez DR, Whitsett JA, Dunussi-Joannopoulos K, Shams H.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):259-68. doi: 10.1164/rccm.201012-2036OC. Epub 2011 Apr 7.

PMID:
21474645
2.

Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.

Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):521-32. doi: 10.1164/rccm.200812-1837OC. Epub 2009 Jul 9.

PMID:
19590023
3.

Delivery of GM-CSF to Protect against Influenza Pneumonia.

Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P, Shams H.

PLoS One. 2015 Apr 29;10(4):e0124593. doi: 10.1371/journal.pone.0124593. eCollection 2015.

4.

Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung.

Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ, Auerbach W, Eynon EE, Stevens S, Manz MG, Flavell RA.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2390-5. doi: 10.1073/pnas.1019682108. Epub 2011 Jan 24.

6.

Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.

Paine R 3rd, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, Reed JA, Ross G, Whitsett JA, Beck JM.

J Immunol. 2000 Mar 1;164(5):2602-9.

7.

GM-CSF modulates pulmonary resistance to influenza A infection.

Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A, Tichelaar JW, White MR, Hartshorn KL, Kobzik L, Whitsett JA, Chroneos ZC.

Antiviral Res. 2011 Nov;92(2):319-28. doi: 10.1016/j.antiviral.2011.08.022. Epub 2011 Sep 8.

8.

FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Abdul-Careem MF, Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG, Chan T, Al-Garawi AA, Chew MV, Yue G, van Roojen N, Xing Z, Ashkar AA.

Antiviral Res. 2011 Nov;92(2):346-55. doi: 10.1016/j.antiviral.2011.09.004. Epub 2011 Sep 14.

PMID:
21945041
9.

GM-CSF and influenza: will saving mice help humans?

Waterer G.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):157-8. doi: 10.1164/rccm.201105-0833ED. No abstract available.

PMID:
21765031
10.

GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization.

Halstead ES, Umstead TM, Davies ML, Kawasawa YI, Silveyra P, Howyrlak J, Yang L, Guo W, Hu S, Hewage EK, Chroneos ZC.

Respir Res. 2018 Jan 5;19(1):3. doi: 10.1186/s12931-017-0708-5.

11.

Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.

Paine R 3rd, Wilcoxen SE, Morris SB, Sartori C, Baleeiro CE, Matthay MA, Christensen PJ.

Am J Pathol. 2003 Dec;163(6):2397-406.

13.

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsushita I, Seymour JF, Oh-Eda M, Ishige I, Eishi Y, Kitamura T, Yamada Y, Hanaoka K, Keicho N.

Blood. 2004 Feb 1;103(3):1089-98. Epub 2003 Sep 25.

14.

Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.

Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ.

J Leukoc Biol. 2006 Jan;79(1):133-9. Epub 2005 Nov 7.

PMID:
16275889
15.

Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages.

Subramaniam R, Mukherjee S, Chen H, Keshava S, Neuenschwander P, Shams H.

Mucosal Immunol. 2016 Jul;9(4):873-83. doi: 10.1038/mi.2015.120. Epub 2015 Nov 18.

PMID:
26577570
16.

GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress.

Baleeiro CE, Christensen PJ, Morris SB, Mendez MP, Wilcoxen SE, Paine R 3rd.

Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1246-55. Epub 2006 Aug 4.

17.

Alveolar epithelial cells orchestrate DC function in murine viral pneumonia.

Unkel B, Hoegner K, Clausen BE, Lewe-Schlosser P, Bodner J, Gattenloehner S, Jan├čen H, Seeger W, Lohmeyer J, Herold S.

J Clin Invest. 2012 Oct;122(10):3652-64. doi: 10.1172/JCI62139. Epub 2012 Sep 10.

18.

Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.

Agostini C, Trentin L, Zambello R, Bulian P, Caenazzo C, Cipriani A, Cadrobbi P, Garbisa S, Semenzato G.

J Immunol. 1992 Nov 15;149(10):3379-85.

PMID:
1431112
19.

Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.

Tan AC, Mifsud EJ, Zeng W, Edenborough K, McVernon J, Brown LE, Jackson DC.

Mol Pharm. 2012 Sep 4;9(9):2710-8. doi: 10.1021/mp300257x. Epub 2012 Aug 3.

PMID:
22823162
20.

Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo.

Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP.

J Biol Chem. 2002 Nov 8;277(45):42808-14. Epub 2002 Sep 2.

Supplemental Content

Support Center